The best of R&I and around the web, handpicked by our editors.
White papers, service directory and conferences for the R&I community.
Web replica of the print magazine.
Total recalled units jumped 27% to 492.31 million in Q1 2026 despite fewer recall events, as tariff volatility, geopolitical disruption and evolving regulations compound product safety risks, according to Sedgwick.
Biotechnology breakthroughs can provide great benefits to society, but the risks can’t be ignored.
A look at the latest legal cases impacting the industry.
Despite heavy regulation, many pharma acquisitions fail from a lack of due diligence.
A California Supreme Court decision clears the way for claims against food producers and retailers.
Long supply chains offer criminals ample opportunities to sneak in counterfeit drugs, which pose a serious risk to public health.
A probe of the nutritional supplement industry may be costly for insurers as well as brand reputations.
As e-cigarette usage rises, danger lies in the lack of regulations and unknown long-term health effects.
Generic drug manufacturers may face increased premiums and higher risk management costs due to a proposed FDA rule.
The risks from the hacking of medical devices needs to be more clearly defined.
A look at the latest decisions impacting the industry.
Complex claims — old and new — call for relationship-building to minimize surprises.
Who could trust a driverless car?
Innovative technology presents unforeseen risk exposures. Presented by Travelers.
Ineffective risk management can cause missteps in recall events that cost millions of dollars.
Amusement parks must balance the desires of customers and the need for safety measures.
The demand for energy drinks is sparking increased focus on safety and liability issues.
A softening market worries reinsurers, but they remain optimistic about growth.
Revolutionary 3D printing processes offer known and unknown risks.